Learned mitochondrial expression patterns associate with kidney cancer survival
Source check: Source checked. Not independent scientific confirmation.
Finding: Consensus clustering and Boruta selection separated mitochondrial-expression patterns in TCGA clear-cell renal cancer data, with different recorded overall survival. Iterative LASSO and survival forests also produced exploratory prognostic models fitted to these data. This is a retrospective association; optimized survival cutoffs and model selection make performance optimistic, and predicted drug sensitivity does not establish treatment response or a therapeutic mechanism.
Technology: Consensus clustering; Boruta; iterative LASSO; random survival forest
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Unsupervised clustering and forest-based feature selection learn mitochondrial-expression patterns that can be compared with recorded survival.
- Test and result
- Outcome associations of unsupervised expression groups and exploratory supervised prognostic fitting using recorded TCGA survival data.
- Limitation / still unknown
- Independent prognostic validation, causal mitochondrial mechanisms and clinical treatment utility remain unestablished; no held-out cohort is described for the reported model performance.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10657316/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.